YMRC
RGEN icon

Yorktown Management & Research Company’s Repligen RGEN Stock Holding History

Yorktown Management & Research Company’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,150
Closed -$309K – 231
2024
Q4 		$309K Hold
2,150
– – 0.3% 168
2024
Q3 		$320K Hold
2,150
– – 0.33% 161
2024
Q2 		$271K Sell
2,150
-900
-30% -$141K 0.29% 175
2024
Q1 		$561K Hold
3,050
– – 0.53% 53
2023
Q4 		$548K Hold
3,050
– – 0.57% 51
2023
Q3 		$485K Sell
3,050
-3,500
-53% -$572K 0.55% 54
2023
Q2 		$927K Sell
6,550
-1,200
-15% -$192K 1% 9
2023
Q1 		$1.3M Hold
7,750
– – 1.41% 7
2022
Q4 		$1.31M Hold
7,750
– – 1.6% 3
2022
Q3 		$1.45M Hold
7,750
– – 1.88% 2
2022
Q2 		$1.26M Sell
7,750
-2,300
-23% -$364K 1.62% 3
2022
Q1 		$1.89M Sell
10,050
-1,000
-9% -$190K 1.6% 4
2021
Q4 		$2.93M Buy
11,050
+1,000
+10% +$269K 1.98% 2
2021
Q3 		$2.9M Hold
10,050
– – 2.18% 1
2021
Q2 		$2.01M Buy
10,050
+800
+9% +$155K 1.57% 5
2021
Q1 		$1.8M Buy
9,250
+100
+1% +$20.5K 1.49% 5
2020
Q4 		$1.75M Hold
9,150
– – 1.58% 2
2020
Q3 		$1.35M Buy
9,150
+1,000
+12% +$143K 1.26% 5
2020
Q2 		$1.01M Buy
8,150
+250
+3% +$29.4K 0.9% 9
2020
Q1 		$763K Hold
7,900
– – 0.77% 20
2019
Q4 		$731K Buy
7,900
+320
+4% +$26.9K 0.39% 93
2019
Q3 		$581K Hold
7,580
– – 0.31% 108
2019
Q2 		$652K Hold
7,580
– – 0.25% 110
2019
Q1 		$448K Buy
+7,580
New +$436K 0.14% 169

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Yorktown Management & Research Company's RGEN Position: Q1 2025 in Review

Yorktown Management & Research Company sold out of Repligen (RGEN) in Q1 2025, closing a stake of 2,150 shares — an estimated $309K sold.

Yorktown Management & Research Company first reported a position in RGEN in Q1 2019 and held it in 24 quarters. The position peaked at $2.93M in Q4 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Yorktown Management & Research Company reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Yorktown Management & Research Company sold 2,150 Repligen shares in Q1 2025, an estimated $309K.
  • Yorktown Management & Research Company first reported a position in Repligen in Q1 2019 and held it in 24 quarters.
  • Yorktown Management & Research Company's Repligen position peaked at $2.93M in Q4 2021.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Yorktown Management & Research Company's 13F filing for Q1 2025, filed 23 Apr 2025.